Sequential administration of XELOX and XELIRI is effective, feasible and well tolerated by patients with metastatic colorectal cancer

Sequential administration of the chemotherapy regimes capecitabine and oxaliplatin (XELOX) and capecitabine and irinotecan (XELIRI) in the first- to second-line treatment setting would allow patients to be managed more easily in an outpatient unit. However, a small number of studies have raised conc...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Oncol Lett
Main Authors: Fukui, Taro, Suzuki, Koichi, Ichida, Kosuke, Takayama, Yuji, Kakizawa, Nao, Muto, Yuta, Hasegawa, Fumi, Watanabe, Fumiaki, Kikugawa, Rina, Saito, Masaaki, Tsujinaka, Shingo, Miyakura, Yasuyuki, Rikiyama, Toshiki
פורמט: Artigo
שפה:Inglês
יצא לאור: D.A. Spandidos 2017
נושאים:
Articles
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5452954/
https://ncbi.nlm.nih.gov/pubmed/28599498
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.6100
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים